绝经前乳癌的辅助内分泌治疗—SERMs

Adjuvant Endocrine Therapy of Premenopausal Breast Cancer-SERMs

他莫昔芬在绝经前乳癌辅助内分泌治疗中仍占主导地位。本文回顾他莫昔芬在乳癌患者中的应用和存在的问题,关注托瑞米芬在绝经前乳癌患者辅助内分泌治疗中的新进展,并对比两者的疗效和安全性。

Tamoxifen is the primary adjuvant endocrine therapy for women of premenopausal breast cancer. We summarized points of debate in the history of tamoxifen and toremifene as endocrine therapy for premenopausal patients,compared effective and side effects of them.